NCT03735966 2022-12-01Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Docetaxel and Carboplatin in HER2 Positive Breast Cancer Patients.Henan Cancer HospitalPhase 2 Completed75 enrolled
NCT01904903 2022-05-10SAFE-HEaRtMedstar Health Research InstitutePhase 2 Completed31 enrolled 12 charts
NCT03947242 2019-05-15Neoadjuvant Study of Pyrotinib and Trastuzumab Plus Vinorelbine in Trastuzumab-refractory HER2-Positive Breast Cancer.Henan Cancer HospitalPhase NA Unknown48 enrolled